AIThe Next Webabout 13 hours ago
Reid Hoffman leaves Microsoft board for AI drug startup Manus
1 min read
Reid Hoffman stepped down from Microsoft's board after nearly a decade to go "founder mode" with Manus, his AI drug discovery startup. Manus has raised over $50 million across two seed rounds with backing from General Catalyst. Hoffman joined Microsoft's board in 2016 after the LinkedIn acquisition and served during key AI deals including the $1 billion OpenAI investment.
Level
Hype check
Tap to vote and see what everyone thinks.
